NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD

Pre Money Equity Valuation
$8,716,118
Min Raise
$5,000,000
Max Raise
$6,000,000
Estimated Close
2018-06-15
Issue Type
IPO
Lead Manager
Westar Capital Ltd
Type of Securities
Shares
Date First Lodged
09/05/2018
Offer Costs $
$560,400
Market Cap Max
$14,716,118
Key Executives
Brian Leedman (NEC), Matthew Liddelow (MD and CEO), Anton Uvarov (ED), Stephen Quantrill (NED)
Company Address
Level 1, 45 Stirling Highway, Nedlands, WA 6009
Stockbroker's Snapshot
Medical drug developer
Exchange
ASX
1st Day VWAP
0.23